Global X Genomics & Biotechnology ETF
GNOM
NASDAQ
| Weiss Ratings | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Valuation | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $69.70 | |||
| Company Info | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Global X Funds | |||
| Manager/Tenure (Years) | Nam To (7), Wayne Xie (7) | |||
| Website | http://www.globalxfunds.com | |||
| Phone Number | 888-493-8631 | |||
| Fund Information | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Global X Genomics & Biotechnology ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Unaligned | |||
| Inception Date | Apr 05, 2019 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.92% | |||
| Dividend | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.17% | |||
| Asset Allocation | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | -0.01% | |||
| Stock | 100.01% | |||
| U.S. Stock | 95.25% | |||
| Non-U.S. Stock | 4.76% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.04% | |||
| 30-Day Total Return | -0.08% | |||
| 60-Day Total Return | 8.44% | |||
| 90-Day Total Return | 23.67% | |||
| Year to Date Total Return | 52.78% | |||
| 1-Year Total Return | 65.37% | |||
| 2-Year Total Return | 66.07% | |||
| 3-Year Total Return | 80.34% | |||
| 5-Year Total Return | -21.30% | |||
| Price | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $68.01 | |||
| 1-Month Low Price | $64.31 | |||
| 1-Month High Price | $72.54 | |||
| 52-Week Low Price | $41.40 | |||
| 52-Week Low Price (Date) | Mar 30, 2026 | |||
| 52-Week High Price | $72.54 | |||
| 52-Week High Price (Date) | Oct 29, 2026 | |||
| NAV | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $64.45 | |||
| 1-Month High NAV | $72.34 | |||
| 52-Week Low NAV | $41.41 | |||
| 52-Week Low NAV (Date) | Mar 27, 2026 | |||
| 52-Week High NAV | $72.34 | |||
| 52-Week High Price (Date) | Oct 29, 2026 | |||
| Beta / Standard Deviation | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.53 | |||
| Standard Deviation | 30.88 | |||
| Balance Sheet | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 102.88M | |||
| Operating Ratios | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.50% | |||
| Turnover Ratio | 34.03% | |||
| Performance | GNOM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 47.91% | |||
| Last Bear Market Total Return | -18.44% | |||